Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Catheter Precision's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $12.83 Mil. Catheter Precision's Total Assets for the quarter that ended in Sep. 2024 was $26.75 Mil.
Therefore, Catheter Precision's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.48.
The historical rank and industry rank for Catheter Precision's Equity-to-Asset or its related term are showing as below:
VTAK'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.84 Med: 0.67 Max: 0.9
Current: 0.48
During the past 8 years, the highest Equity to Asset Ratio of Catheter Precision was 0.90. The lowest was -0.84. And the median was 0.67.
VTAK's Equity-to-Asset is ranked worse than 69.15% of 872
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs VTAK: 0.48
Catheter Precision Equity-to-Asset Historical Data
The historical data trend for Catheter Precision's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Catheter Precision's Equity-to-Asset
For the Medical Devices subindustry, Catheter Precision's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Catheter Precision's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Catheter Precision's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Catheter Precision Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Catheter Precision's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VTAK has been successfully added to your 